February 17, 2022A new treatment for depression is more effective and works eight times faster than the current approved protocol, according to a small randomized control trial published recently in The American Journal of Psychiatry1.
The new treatment is called Stanford neuromodulation therapy (SNT), an intermittent theta-burst stimulation2 (iTBS) that delivers magnetic pulses to the brain region thought to be implicated in depression.SNT (previously referred to as Stanford accelerated intelligent neuromodulation therapy or SAINT) builds on iTBS treatment, a U.S.
Food and Drug Administration-approved noninvasive brain stimulation protocol for treatment-resistant depression. The FDA has deemed iTBS safe, however traditional iTBS treatment is delivered every day for six weeks and results vary broadly by case.
Read more on additudemag.com